- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/705 - ReceptorsCell surface antigensCell surface determinants
Patent holdings for IPC class C07K 14/705
Total number of patents in this class: 14813
10-year publication summary
|
646
|
758
|
943
|
1061
|
1102
|
1294
|
1264
|
1203
|
1192
|
788
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20059 |
319 |
| The Trustees of the University of Pennsylvania | 4337 |
316 |
| The Board of Trustees of the Leland Stanford Junior University | 6451 |
208 |
| Memorial Sloan-Kettering Cancer Center | 1945 |
183 |
| Regeneron Pharmaceuticals, Inc. | 4323 |
182 |
| Board of Regents, The University of Texas System | 5849 |
168 |
| Immatics Biotechnologies GmbH | 1153 |
152 |
| Novartis AG | 10730 |
142 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2869 |
129 |
| The General Hospital Corporation | 4759 |
92 |
| City of Hope | 996 |
87 |
| Autolus Limited | 255 |
82 |
| Dana-Farber Cancer Institute, Inc. | 2585 |
80 |
| CRISPR Therapeutics AG | 368 |
78 |
| Alpine Immune Sciences, Inc. | 80 |
73 |
| Baylor College of Medicine | 961 |
73 |
| Juno Therapeutics, Inc. | 417 |
67 |
| Lentigen Technology, Inc. | 100 |
67 |
| The Johns Hopkins University | 5709 |
65 |
| Fred Hutchinson Cancer Center | 451 |
65 |
| Other owners | 12185 |